Mylan reaches agreement with Aspen for their European thrombosis business
September 8, 2020Manufacturing and Production Mylan, aspen
Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million. …
Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme
September 8, 2020Manufacturing and Production China Vaccine, China Vaccine approval, coronavirus vaccine
Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according …
Up to 60,000 in the UK may have suffered from “long COVID” new data suggests
September 8, 2020Manufacturing and Production Vaccine, pandemic, vaccines
60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …
Genetech scores sixth FDA approval in lung cancer with Gavreto
September 7, 2020Sales and Marketing Cancer, FDA, Genentech, lung cancer
Genentech’s once-daily oral therapy Gavreto (pralsetinib) has secured FDA backing in the treatment of metastatic rearranged during transfection (RET) fusion-positive …
President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros
September 7, 2020Sales and Marketing COVID-19, GSK, Sanofi
The President of Sanofi France expects the coronavirus vaccine it is developing with GlaxoSmithKline to be priced under 10 Euros. …
Janssen’s Imbruvica secures label expansion in Europe in chronic lymphocytic leukaemia
September 7, 2020Sales and Marketing Europe, Janssen, imbruvica, pharma
The European Commission (EC) has moved to expand the existing approval of Janssen’s Imbruvica (ibrutinib) in chronic lymphocytic leukaemia (CLL) …
FDA rejects oleandrin as a dietary supplement, after being touted by major Trump ally as a coronavirus treatment
September 7, 2020Sales and Marketing FDA, coronavirus, fda treatment
The FDA has rejected a submission from Phoenix Biotechnology to market oleandrin as a dietary supplement. Phoenix Biotechnology submitted oleandrin …
New poll indicates most Americans will not get a COVID-19 vaccine when it’s first available
September 7, 2020Sales and Marketing COVID, COVID-19, COVID-19 vaccine, coronavirus
Two-thirds of Americans say they will not get vaccinated against COVID-19 when a treatment first becomes available, according to a …
Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients
September 4, 2020Medical Communications, Research and Development COVID-19, pharma, steroids
A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …
Operation Warp Speed’s top doctor says coronavirus vaccine likely won’t be approved until after November
September 4, 2020Medical Communications
Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the …
Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters
September 4, 2020Medical Communications COVID-19, J&J, JJ
Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.
Akebia Therapeutics’ HIF-PH inhibitor passes efficacy goals in chronic kidney disease without dialysis, but falls short on safety
September 4, 2020Medical Communications, Research and Development Akebia Therapeutics, kidney disease, pharma, vadadustat
Akebia Therapeutics has pulled back the veil on data from the second of two Phase 3 clinical trials for its …
Top Ten most popular articles on Pharmafile.com this week
September 4, 2020Medical Communications
The top 10 news stories this week largely cover coronavirus, as Sanofi is halting clinical trials treating serious COVID-19 patients …
NICE knocks back Janssen’s Spravato nasal spray for the second time in treatment-resistant depression
September 3, 2020Sales and Marketing Janssen, Spravato, depression, pharma
NICE has opted to reject Janssen’s nasal spray Spravato (esketamine) for routine use on the NHS for treatment-resistant major depressive …
MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme
September 3, 2020Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma
It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …
Four COVID-19 vaccine trials backed by Operation Warp Speed will likely fail, according to a new report
September 3, 2020Research and Development
Four late-stage trials of vaccine candidates partly funded by the US Operation Warp Speed are likely to fail, according to …
Ted Cruz and 19 other GOP Senators ask FDA to remove Danco’s abortion drug Mifeprex from the market
September 3, 2020Manufacturing and Production Mifeprex, abortion
Texas Senator Ted Cruz and 19 other senators have sent a letter to the FDA urging them to take the …
J&J issues warning after teen dies from Benadryl TikTok challenge
September 3, 2020Medical Communications
One teen has died after taking large amounts of the antihistamine Benadryl as part of a social media “challenge” on …
Gilead and Jounce Therapeutics forge immuno-oncology partnership worth a potential $700m+
September 2, 2020Research and Development, Sales and Marketing Gilead, jounce, oncology, pharma
Gilead and Jounce Therapeutics have come together in a new immuno-oncology partnership potentially worth over $700 million. The primary drive …
US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO
September 2, 2020Research and Development Trump, Trump Administration, US, USA
The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.COVAX is …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
